The Technology Transfer Cycle

The volume contains papers of the International Conference on technology transfer “The technology Transfer Cycle” held on 13th April, 2018 at the University of Urbino and organized by the Third Mission Office. The principal aim of the conference was to provide the basis for a better understanding of the concept of the technology transfer cycle with a specific focus on the biomed and biotech reasearch fields, which includes the involvement of companies, rare genetic desease and oncologic patients and the market. The invited speakers were asked to address the following main topics: 1) Understand how medtech companies intercept the needs of rare genetic disease patients and oncologic patients and consequently plan their research for product development in order to address these demands Are patients and their families effectively involved by companies in their research decision making process? At which stage farmaceutical companies consider patient engagement across the product lifecycle, from clinical development through product launch? Which are the benefits for companies that maximize direct patients engagement strategies? 2) Understand the ways through which research results reach the market to satisfy the needs of the patients affected by these patologies. How do medtech companies intercept University research results? Are patents an effective technology transfer mode from Universities to companies? Which are the academic patent transfer modes to reach life science companies? Which companies are interested in Italian University life science patents? How can they be identified? How do research result reach the patients? Which are the benefits of the overall technology transfer cycle for patients? The published papers are miscellaneous as they include researches carried out over the last few years on the topic addressed, reports based on the professional experience of the speaker in the field and a transcription of the speaker’s slide presentation.